Myeloproliferative neoplasms (MPNs) are clonal hematopoietic disorders that cause excessive production of myeloid cells. Most MPN patients have a point mutation in
JAK2
(
JAK2
V617F
), which encodes a dominant-active kinase that constitutively triggers JAK/STAT signaling. In
Drosophila
, this pathway is simplified, with a single JAK, Hopscotch (Hop), and a single STAT transcription factor, Stat92E. The
hop
Tumorous-lethal
[
hop
Tum
] allele encodes a dominant-active kinase that induces sustained Stat92E activation. Like MPN patients,
hop
Tum
mutants have significantly more myeloid cells, which form invasive tumors. Through an unbiased genetic screen, we found that heterozygosity for
Enhancer of Polycomb
[
E(Pc)
], a component of the Tip60 lysine acetyltransferase complex (also known as KAT5 in humans), significantly increased tumor burden in
hop
Tum
animals. Hematopoietic depletion of
E(Pc)
or other Tip60 components in an otherwise wild-type background also induced blood cell tumors. The
E(Pc)
tumor phenotype was dependent on JAK/STAT activity, as concomitant depletion of
hop
or
Stat92E
inhibited tumor formation. Stat92E target genes were significantly upregulated in
E(Pc)-
mutant myeloid cells, indicating that loss of
E(Pc)
activates JAK/STAT signaling. Neither the
hop
nor
Stat92E
gene was upregulated upon hematopoietic
E(Pc)
depletion, suggesting that the regulation of the JAK/STAT pathway by E(Pc) is dependent on substrates other than histones. Indeed,
E(Pc)
depletion significantly increased expression of Hop protein in myeloid cells. This study indicates that E(Pc) works as a tumor suppressor by attenuating Hop protein expression and ultimately JAK/STAT signaling. Since loss-of-function mutations in the human homologs of E(Pc) and Tip60 are frequently observed in cancer, our work could lead to new treatments for MPN patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.